BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Alimera Sciences 

6120 Windward Parkway
Suite 290
Alpharetta  Georgia  30005  U.S.A.
Phone: 678-990-5740 Fax: 678-990-5744


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
Alimera Sciences (ALIM) To Present At Ophthalmology Innovation Summit At The American Academy of Ophthalmology Annual Meeting 10/9/2014 9:29:31 AM
Alimera Sciences (ALIM) Receives $25 Million Advance From Hercules Technology Growth Capital 10/1/2014 7:43:22 AM
Alimera Sciences (ALIM), pSivida Corp (PSDV) Eye Implant Finally Wins FDA Approval 9/26/2014 4:21:11 PM
Alimera Sciences (ALIM)' Iluvien® Receives Tenth National Marketing Authorization For The Treatment Of Chronic Diabetic Macular Edema 9/4/2014 11:20:58 AM
Alimera Sciences (ALIM) Reports Second Quarter 2014 Financial Results 8/8/2014 8:16:46 AM
Alimera Sciences (ALIM)' ILUVIEN® Receives Marketing Authorization In Denmark For The Treatment Of Chronic Diabetic Macular Edema 8/1/2014 6:43:27 AM
Alimera Sciences (ALIM)' ILUVIEN® Receives Marketing Authorization In Norway For The Treatment Of Chronic Diabetic Macular Edema 7/29/2014 7:40:31 AM
Alimera Sciences (ALIM) To Release Second Quarter 2014 Results 7/25/2014 8:07:34 AM
Alimera Sciences (ALIM)' ILUVIEN® Receives Positive Outcome Of Repeat-Use Procedure For 10 Additional European Countries 6/30/2014 9:58:01 AM
Alimera Sciences (ALIM)' ILUVIEN® Receives Marketing Authorization In Italy For The Treatment Of Chronic Diabetic Macular Edema 6/23/2014 6:41:55 AM
12345678910...